Moderna makes commercial case for COVID-19 vaccine amid price pressure
Moderna Therapeutics reveals it is selling its COVID-19 vaccine for up to $37 a dose, well above the amount charged by some of its rivals.
Archives for August 10, 2020
Allogene CAR-T plant on track despite ‘minor delays’ due to COVID-19
Allogene Therapeutics maintains 2021 completion date for US CAR-T manufacturing facility despite COVID-19 causing “minor delays.”
Fate touts potential to make 15,000 cell therapy doses per cGMP run
Fate Therapeutics touts potential to make cell therapies from renewable cell lines at scale after early production success.